✦ LIBER ✦

Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumours

✍ Scribed by Romer, A.; Seiler, D.; Marincek, N.; Brunner, P.; Koller, M. T.; Ng, Q. K. T.; Maecke, H. R.; Müller-Brand, J.; Rochlitz, C.; Briel, M.; Schindler, C.; Walter, M. A.

Book ID: 121572996
Publisher: Springer
Year: 2013
Tongue: English
Weight: 426 KB
Volume: 41
Category: Article
ISSN: 0340-6997
DOI: 10.1007/s00259-013-2559-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with tandem [90Y]DOTA-TATE and

Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy

✍ Seregni, E.; Maccauro, M.; Chiesa, C.; Mariani, L.; Pascali, C.; Mazzaferro, V.; 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 329 KB

Somatostatin-based radiotherapy with [90

Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors: long-term outcome of a phase I dose escalation study

✍ Nicolas Marincek, Ann-Catherine Jörg, Philippe Brunner… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 610 KB